Linde Louise, Sørensen Jan, Ostergaard Mikkel, Hørslev-Petersen Kim, Hetland Merete Lund
Department of Rheumatology, Copenhagen University Hospital, Hvidovre, Denmark.
J Rheumatol. 2008 Aug;35(8):1528-37. Epub 2008 May 15.
To compare validity, reliability, and responsiveness of generic and disease specific health-related quality of life (HRQOL) instruments in rheumatoid arthritis (RA).
Two samples of patients completed the Medical Outcomes Study Short Form-36 Health Survey (SF-36), EuroQol (EQ)-5D, 15D, Rheumatoid Arthritis Quality of Life Scale (RAQoL), Health Assessment Questionnaire (HAQ), and visual analog scales (VAS) for pain, fatigue, and global RA. VALIDITY (convergent, discriminant, and known-groups) was evaluated in a cross-section of 200 patients. Reliability was evaluated by agreement (intraclass correlation coefficient; baseline to 2 weeks) and internal consistency (Cronbach's alpha); and responsiveness by the standardized response mean stratified on improvement, status quo, or deterioration in health status after 6 months in 150 patients followed longitudinally. Followup questionnaires (at 2 weeks and 6 months) included questions about changes in health status since baseline.
The cross-sectional sample included 77% women, median age 57 years (range 19-87), disease duration 6 years (0-58), with Disease Activity Score 28-joint count (DAS28) of 3.10 (1.21-6.47). The longitudinal sample included 80% women, median age 60 years (22-82).
all instruments discriminated between low, moderate, and high DAS28. Reliability: RAQoL and HAQ displayed good repeatability (ICC > 0.95) and internal consistency (Cronbach's alpha > 0.90). Responsiveness: SF-36 bodily pain scale and VAS pain were responsive to both improvement and deterioration.
All instruments were valid measures for HRQOL in RA. The RAQoL and HAQ displayed the best reliability, while the SF-36 bodily pain scale and VAS pain were the most responsive. The choice of instrument should depend on the study objectives.
比较通用型和疾病特异性健康相关生活质量(HRQOL)工具在类风湿关节炎(RA)中的有效性、可靠性和反应性。
两组患者样本完成了医学结局研究简明健康调查(SF - 36)、欧洲五维健康量表(EQ - 5D)、15D、类风湿关节炎生活质量量表(RAQoL)、健康评估问卷(HAQ)以及疼痛、疲劳和类风湿关节炎整体状况的视觉模拟量表(VAS)。在200例患者的横断面样本中评估有效性(收敛效度、区分效度和已知组效度)。通过一致性(组内相关系数;基线至2周)和内部一致性(克朗巴哈系数)评估可靠性;通过150例纵向随访6个月后根据健康状况改善、维持现状或恶化分层的标准化反应均值评估反应性。随访问卷(2周和6个月时)包括自基线以来健康状况变化的问题。
横断面样本中77%为女性,中位年龄57岁(范围19 - 87岁),病程6年(0 - 58年),28个关节疾病活动评分(DAS28)为3.10(1.21 - 6.47)。纵向样本中80%为女性,中位年龄60岁(22 - 82岁)。
所有工具均能区分低、中、高DAS28水平。可靠性:RAQoL和HAQ显示出良好的重复性(组内相关系数>0.95)和内部一致性(克朗巴哈系数>0.90)。反应性:SF - 36身体疼痛量表和VAS疼痛量表对改善和恶化情况均有反应。
所有工具均是评估类风湿关节炎患者HRQOL的有效方法。RAQoL和HAQ显示出最佳的可靠性,而SF - 36身体疼痛量表和VAS疼痛量表反应性最强。工具的选择应取决于研究目的。